July 19, 2010
Sabin Vaccine Institute announced today that Dr. Neeraj Mistry has been appointed Managing Director of the Global Network for Neglected Tropical Diseases (Global Network). Dr. Mistry will focus his talents on advocacy and resource mobilization efforts, creatively bringing likeminded groups and individuals together for the common purpose of controlling and eliminating neglected tropical diseases (NTDs).
“We are delighted that Dr. Mistry is joining the Global Network, where he will bring intellectual leadership and creative thinking to the development of the program’s important mission and goals.” said Michael W. Marine, CEO of the Sabin Vaccine Institute. “His exceptional research, planning and evaluation skills, as well as his extensive international experience, will help the Global Network achieve its overarching goal of bringing new resources to the fight against NTDs in endemic countries around the world.”
A public health physician, Dr. Mistry was a founding member and former vice president of the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria (GBC), and brings extensive experience in global health policy and programming, having worked in developing and developed countries, in the public and private sectors in clinical practice, health policy and social development.
While at GBC, Dr. Mistry provided substantive and strategic input to the organization’s regional offices and departments. He developed the Business AIDS Methodology (BAM™) and Best Practice AIDS Standard (BPAS™) and conceptualized and led GBC’s work on co-investment and public-private partnerships with the President’s Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund, where he continues to support the technical review panel.
“I’m honored to join an organization with a challenging and compelling mission,” said Dr. Mistry. I feel privileged to support sustainable, innovative and results-oriented projects and approaches to aiding in the control and elimination of NTDs, arguably one of today’s most pressing global health concerns.”
Following the completion of his medical training at the University of the Witwatersrand Medical School in Johannesburg, South Africa, Dr. Mistry focused on HIV/AIDS, occupational health, family practice and sexual and reproductive health. Dr. Mistry also worked at the National Health Service (NHS) in London and with Merck & Co. Inc.dealing with public affairs for Europe, the Middle East and Africa. He holds a Master’s degree in health policy and economics from the London School of Economics and Political Science. He is currently reading for a Masters in Liberal Arts at Johns Hopkins.
“Dr. Mistry will play a vital role in guiding our strategic progress moving forward. His tremendous experience and expertise will build on the remarkable momentum the Global Network has achieved in recent years and fortify our rapidly growing team,” said Sabin Vaccine Institute President Dr. Peter Hotez.
About the Global Network for Neglected Tropical Diseases
The Global Network for Neglected Tropical Diseases, a major program of the Sabin Vaccine Institute, is an advocacy and resource mobilization initiative dedicated to eliminating the most common disabling, disfiguring and deadly neglected tropical diseases (NTDs). Through a network of partnering international agencies, scientists and advocates, the Global Network aims to raise the awareness, political will, and funding necessary to control and eliminate the seven most common NTDs that afflict and stigmatize 1.4 billion of the world’s poorest people. www.globalnetwork.org
About Sabin Vaccine Institute
Sabin Vaccine Institute is a non-profit, 501(c)(3) organization of scientists, researchers, and advocates dedicated to reducing needless human suffering from infectious and neglected tropical diseases (NTDs) through prevention and treatment. Sabin works with governments, academic institutions, scientists, medical professionals, and other non-profit organizations to provide short and long-term solutions for some of the globe’s toughest health care challenges. Since its founding in 1993 in honor of the oral polio vaccine developer, Dr. Albert B. Sabin, the Institute has been at the forefront of global efforts to eliminate, prevent and cure infectious and neglected tropical diseases by developing new vaccines, establishing international networks and advocating for effective and efficient delivery of preventions and treatments to the world’s poor. www.sabin.org